PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, providing promising developments across numerous health-related and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, extra responsible choice for therapeutic use, es